Research and Policy CSR News

Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use

Summary: 
  • FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
  • The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
  • BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
  • Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
  • Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test

 

Press Release
  • FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
  • The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
  • BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
  • Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
  • Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test

 

How Do We Help Prevent the Next Pandemic? Collaboration.

Our Pandemic Defense Coalition is here to help stop future pandemics in their tracks through global partnership.
Blog

We think it's safe to say, nobody ever wants to endure another pandemic. COVID-19 emphasized the importance of preparedness and containing viral threats before they reach every corner of the world.

IWBI Welcomes New Organizations to Its Growing Membership Program

IWBI members are investing in the health and well-being of their employees, clients and customers
Press Release

New York, March 29, 2021 /3BL Media/ – The International WELL Building Institute (IWBI) is pleased to announce new organizations that have joined the IWBI membership program. The continued growth of the program signifies an increasing global emphasis on improving health and well-being through the spaces where we live, work and play. The most recent members to join this network include real estate developers, design and engineering consulting firms and product manufacturers.

O-I Foundation Gifts $50k to Facilitate COVID-19 Vaccine Access in the Region

Donation Kicks Off Fundraising Efforts for Education and Logistics Through VProject
Press Release

PERRYSBURG, OH, April 7, 2021 /3BL Media/ – O-I Glass, Inc. (NYSE: O-I) announced today that it has gifted $50k to the Victory Over COVID-19 Through Vaccination (VProject) through its O-I Charitable Foundation. As Northwest Ohio prepares to enter Phase 1B for vaccine distribution, the VProject is engaging more than 250 community leaders to ensure vaccine access and information to all populations represented in the area.

LIVE WEBCAST: International WELL Building Institute to Lead Live Webcast Focusing on Climate Change, Human Health and the Built Environment

Experts share how environmental and human health research can support in the fight against climate change, highlighting the various mechanisms that are needed to make an impact.
Article

LIVE Webcast | Register here

DATE: April 1, 2021

TIME: 12 p.m. (ET)

Facilitator:

  • Whitney Austin Gray, Ph.D., Senior Vice President, Research, IWBI

Speakers:

How We're Tracking COVID-19 Variants

Our scientists have analyzed viruses for decades. Now, their work is in the spotlight as COVID-19 variants emerge.
Blog

Viruses mutate. They’re tenacious. We know this. It's why our monitoring remains vigilant.

Now, as COVID-19 variants emerge across the globe, Abbott scientists — Virus Hunters to us — are helping the global effort to track known variants and identify new ones.

We asked Mary Rodgers, Ph.D., principal scientist and head of Abbott’s Global Viral Surveillance Program, to walk us through how this crucial work is done.

Alkermes: How Substance Use Disorder Changes the Brain

Multimedia with summary

Substance Use Disorder is associated with changes in the brain that can occur with repeated use of alcohol or drugs. Learn more about this condition here: https://bit.ly/2OlyWxY.

Alkermes Celebrates Brain Awareness Week

Multimedia with summary

It's Brain Awareness Week! Raising awareness & advocating for research funding is crucial to improving the lives of people with schizophrenia & bipolar disorder. Each year, we work to understand the effects these diseases have on the brain and help people living with these conditions.

A Conversation With Julie Kim and Rajeev Venkayya Reflecting on an Extraordinary Year

Blog

2020 was an extraordinary year – unlike most of us have ever seen before. Throughout the COVID-19 pandemic, many of us have faced both professional and personal challenges in adapting to our new reality. We’re looking beyond the science with two of Takeda’s leaders, Julie Kim, President of the Plasma-Derived Therapies Business Unit, and Rajeev Venkayya, President of the Vaccine Business Unit, to explore how Takeda adapted to this new normal while continuing to deliver for patients.

Pages

Subscribe to Research and Policy